WHEN BECTON DICKINSON (BD) ANNOUNCED ITS INTENT to spin off its in vitro diagnostics (IVD) and life sciences units in February, few observers expected a deal to close just five months later. But now that such an agreement has occurred as of July 14, the buyer—Waters Corporation—finds itself dropped into a competitive industry that is […]
To access this post, you must purchase The Dark Report.